Castelló d’Empúries, Girona – June 2025. Skin Tech Pharma Group, a leader in aesthetic medical solutions, won the “Premi a la Pime més competitiva” (Most Competitive SME Award) in the Medium-Sized Company category.
This award marks a key year for the company. Its flagship product, RRS® HA Long Lasting, drove strong international growth. This innovative injectable device introduces a new category in aesthetic medicine: the Skin Builder. It combines cross-linked hyaluronic acid with 15 specific amino acids to regenerate, strengthen, and rejuvenate the skin. Medical professionals worldwide endorse its natural and proven results.
In 2024, Skin Tech Pharma Group expanded its global presence significantly. In 2025, it plans to open new branches in Spain and China to strengthen its international reach.
To support this growth, the company will soon open a 6,000 m² production facility. This state-of-the-art site will increase manufacturing capacity while maintaining high standards for quality, innovation, and local production.
The company is also experiencing strong financial momentum. In June 2024, Charterhouse joined its capital structure as a strategic investment partner. This step reinforces the company’s vision and accelerates its plans for R&D, innovation, and global expansion.
The award was received by Marcio Rodrigues, CEO of Skin Tech Pharma Group, and presented by the President of the Generalitat, Salvador Illa.
